The PanOptix Trifocal Intraocular Lens (IOL) for Cataract Surgery or Refractive Lens Exchange

The PanOptix Trifocal Lens is a new form of intraocular lens or IOL, which allow three ranges of clear vision for cataract patients or patients seeking clear vision at near, far and intermediate through refractive lens exchange. This new type of IOL has been used in over 70 countries, but was approved by the Food and Drug Administration for use in the U.S. in 2019. Prior to their approval, medical studies have shown that these trifocal lenses are safe and effective, with 99 percent of trial participants reporting that they are very satisfied with the results.

Who should consider The PanOptix Trifocal Intraocular Lens (IOL)?

Cataract surgery removes a patient’s cloudy lens and replaces it with a new, clear lens. When patients choose a standard lens for their procedure, they are limited to a lens that will correct either distance vision or near vision. Cataract surgery with a standard monofocal lens clears up blurry, clouded vision. However, many patients find they still need glasses for near work or to see far distances.

The AcrySof PanOptix trifocal intraocular lens provides patients with or without astigmatism clear vision at near, intermediate and far after cataract procedures or after refractive lens exchange. This lens enables patients to see everything clearly, from the morning paper, to the desktop computer, to road signs, to scenic landscapes with less dependency on glasses. The PanOptix Trifocal Lens provides an outstanding range of vision without blurry zones, so patients can focus without straining.

Who is a candidate for the PanOptix Trifocal IOL?

An ideal patient for the PanOptix trifocal lens has generally healthy eyes aside from the cataracts and either desires to reduce their dependence on glasses or is open to information on different lenses. It is important that patients are educated on the options that exist for lens implantation and to remind them that it is possible to reduce their dependence on glasses. Once a patient is well-educated, he or she can then make an informed decision.

Patients with high expectations for total spectacle independence or perfectionistic personalities may not be good candidates for any diffractive optic lens.

Anyone who is a candidate for cataract surgery should be educated and consider the PanOptix trifocal lens. It is a miraculous advancement for cataract patients or patients seeking less dependency on glasses through a refractive lens exchange. Dr. Zaffater is one of the first physicians in Louisiana to offer the PanOptix lens to patients since its approval in August of 2019. He has been overwhelmed with the outcomes patients are receiving with the PanOptix lens.

Get Started Today

Call our office today and schedule an appointment to see if you are a candidate for the life changing, PanOptix lens!